Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity. (Q30376724)

21 June 2017

1 reference

title

Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity. (English)

1 reference

21 June 2017

1 reference

Adam Kenneth Wheatley

series ordinal

1

0 references

Stephen J. Kent

object named as

Stephen John Kent

series ordinal

2

0 references

publication date

15 July 2015

1 reference

Expert Review of Vaccines

21 June 2017

published in

1 reference

21 June 2017

volume

14

1 reference

21 June 2017

issue

9

1 reference

21 June 2017

page(s)

1227-1239

1 reference

New world bats harbor diverse influenza A viruses

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Influenza virus evolution, host adaptation, and pandemic formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Recurring influenza B virus infections in seals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Outbreak of variant influenza A(H3N2) virus in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Emergence in China of human disease due to avian influenza A(H10N8)--cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

The genesis and source of the H7N9 influenza viruses causing human infections in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

The emergence and diversification of panzootic H5N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Cross-protective immunity to influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Immunity to seasonal and pandemic influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Cross-neutralization of influenza A viruses mediated by a single antibody loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Antibody recognition of a highly conserved influenza virus epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A highly conserved neutralizing epitope on group 2 influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A common solution to group 2 influenza virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Highly Conserved Protective Epitopes on Influenza B Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Mechanisms of hemagglutinin targeted influenza virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Influenza virus antigenicity and broadly neutralizing epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Adjuvanted influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Universal influenza virus vaccines: need for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

M2e-Based Universal Influenza A Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Advancements in the development of subunit influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Development of universal influenza vaccines based on influenza virus M and NP genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Identification of a highly conserved and surface exposed B-cell epitope on the nucleoprotein of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Cellular immune correlates of protection against symptomatic pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Disquisitions on Original Antigenic Sin. II. Proof in lower creatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Disquisitions of Original Antigenic Sin. I. Evidence in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

High preexisting serological antibody levels correlate with diversification of the influenza vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Influence of prior influenza vaccination on antibody and B-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Seasonal influenza vaccine provides priming for A/H1N1 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

The contribution of animal models to the understanding of the host range and virulence of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Influenza vaccine immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Lineage structure of the human antibody repertoire in response to influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Cutting Edge: CD4 T Cells Generated from Encounter with Seasonal Influenza Viruses and Vaccines Have Broad Protein Specificity and Can Directly Recognize Naturally Generated Epitopes Derived from the Live Pandemic H1N1 Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

The structure and receptor binding properties of the 1918 influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1068125

10.1586/14760584.2015.1068125

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference